| Product Code: ETC12732942 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Neoantigen Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Neoantigen Market Revenues & Volume, 2021 & 2031F |
3.3 India Neoantigen Market - Industry Life Cycle |
3.4 India Neoantigen Market - Porter's Five Forces |
3.5 India Neoantigen Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Neoantigen Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 India Neoantigen Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 India Neoantigen Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Neoantigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing investments in research and development for personalized medicine |
4.2.3 Rising awareness about the benefits of immunotherapy in cancer treatment |
4.3 Market Restraints |
4.3.1 High costs associated with neoantigen-based therapies |
4.3.2 Lack of skilled professionals in the field of personalized medicine |
4.3.3 Stringent regulatory requirements for approval of neoantigen therapies |
5 India Neoantigen Market Trends |
6 India Neoantigen Market, By Types |
6.1 India Neoantigen Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Neoantigen Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 India Neoantigen Market Revenues & Volume, By Personalized Neoantigens, 2021 - 2031F |
6.1.4 India Neoantigen Market Revenues & Volume, By Shared Neoantigens, 2021 - 2031F |
6.2 India Neoantigen Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 India Neoantigen Market Revenues & Volume, By DNA Sequencing, 2021 - 2031F |
6.2.3 India Neoantigen Market Revenues & Volume, By RNA Sequencing, 2021 - 2031F |
6.2.4 India Neoantigen Market Revenues & Volume, By Mass Spectrometry, 2021 - 2031F |
6.3 India Neoantigen Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 India Neoantigen Market Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031F |
6.3.3 India Neoantigen Market Revenues & Volume, By Vaccine Development, 2021 - 2031F |
6.3.4 India Neoantigen Market Revenues & Volume, By Drug Discovery, 2021 - 2031F |
6.4 India Neoantigen Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Neoantigen Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 India Neoantigen Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.4 India Neoantigen Market Revenues & Volume, By Biotechnology Companies, 2021 - 2031F |
7 India Neoantigen Market Import-Export Trade Statistics |
7.1 India Neoantigen Market Export to Major Countries |
7.2 India Neoantigen Market Imports from Major Countries |
8 India Neoantigen Market Key Performance Indicators |
8.1 Number of clinical trials involving neoantigen-based therapies in India |
8.2 Adoption rate of personalized medicine in cancer treatment |
8.3 Growth in funding for neoantigen research and development |
9 India Neoantigen Market - Opportunity Assessment |
9.1 India Neoantigen Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Neoantigen Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 India Neoantigen Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 India Neoantigen Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Neoantigen Market - Competitive Landscape |
10.1 India Neoantigen Market Revenue Share, By Companies, 2024 |
10.2 India Neoantigen Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here